Efficacy and Safety of LAIS® Mites Sublingual Tablets

Summary

Evaluation of the efficacy and safety of SLIT with LAIS® Mites Sublingual tablets compared to standard drug treatment in patients aged over 60 years suffering from house dust mite (HDM) induced allergic rhino-conjunctivitis with/without asthma.

Timeline

Start

2014-10

Primary completion

2016-07

Completion

2016-12

Drugs

Indications